GRAIL logo

GRAIL

GRAL | NASDAQ
Chart Builder DCF Calculator
$105.60
-$10.29 (-8.88%)
At close: Nov 16, 2026, 4:00 PM ET
$106.90
+$1.30 (+1.23%)
After-hours: Nov 16, 2026, 7:51 PM ET
-8.88%

Rating

Updated: Nov 16, 2026
42.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #457/1021 (Top 45%)

Key Statistics

Market Data

Market Cap $4.75B
1D Range
104.65 113.06
52W Range
43.03 158.92

Valuation (TTM)

PE -11.12
PB 1.94
EV/EBITDA -10.29

Valuation (NTM)

Forward PE N/A
Forward PEG 0.76
Price Target $118.00
Loading financial charts...

Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for ...

Sector Healthcare
Employees 910
IPO Date Jun 12, 2024
Fiscal Year January - December

Latest News

GRAIL, Inc. (GRAL) Presents at 2026 UBS Global Healthcare Conference Transcript

6 days ago · seekingalpha.com

GRAIL, Inc. (GRAL) Presents at 2026 UBS Global Healthcare Conference Transcript
Her Doctor Will Order a $949 Blood Test That Screens for Multiple Cancers. Medicare Will Pay $0 Toward the Test, Leaving Her With the Entire Bill Before Any Coverage Decision in 2029

7 days ago · 247wallst.com

Her Doctor Will Order a $949 Blood Test That Screens for Multiple Cancers. Medicare Will Pay $0 Toward the Test, Leaving Her With the Entire Bill Before Any Coverage Decision in 2029
GRAIL Q3 Earnings Call Ties FDA Review to Pricing and Sales Growth

12 days ago · zacks.com

GRAIL Q3 Earnings Call Ties FDA Review to Pricing and Sales Growth
GRAIL, Inc. (GRAL) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

GRAIL, Inc. (GRAL) Q3 2026 Earnings Call Transcript
What GRAIL (GRAL) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What GRAIL (GRAL) Said on Its Q3 Earnings Call
GRAIL Reports Third Quarter 2026 Financial Results

12 days ago · prnewswire.com

GRAIL Reports Third Quarter 2026 Financial Results
GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth

19 days ago · zacks.com

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth
GRAIL to Present at the UBS Global Healthcare Conference

20 days ago · prnewswire.com

GRAIL to Present at the UBS Global Healthcare Conference
GRAIL to Announce Third Quarter 2026 Financial Results

26 days ago · prnewswire.com

GRAIL to Announce Third Quarter 2026 Financial Results
First-Class Amenity Kits Have Become Holy Grail Collectibles

1 month ago · wsj.com

First-Class Amenity Kits Have Become Holy Grail Collectibles

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$2.21
Beat +13.67%
REV
$37.54M
Miss -15.09%
Next Earnings
Feb 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$118.00
Upside
+11.74%
Buy (5)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.